APO Research
Talk to an analyst

APO RESEARCH · REPORT

TYK2 Targeting Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global TYK2 Targeting Drugs Market Outlook and Growth Opportunities 2026

29 December 2025199 pages

Choose your research edition.

Industry ResearchTYK2 Targeting Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal TYK2 Targeting Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal TYK2 Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TYK2 Targeting Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal TYK2 Targeting Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global TYK2 Targeting Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the TYK2 Targeting Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the TYK2 Targeting Drugs market include Inventisbio, Qiyuan Biotechnology, InnoCare, Guangzhou Zaiji Pharmaceutical, Changzhou Hengbang Pharmaceutical, BeiGene, Ventyx Biosciences, Takeda (Nimbus Therapeutics) and Sareum Holdings Pic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global TYK2 Targeting Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of TYK2 Targeting Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents TYK2 Targeting Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the TYK2 Targeting Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

TYK2 Targeting Drugs Segment by Company

Inventisbio

Qiyuan Biotechnology

InnoCare

Guangzhou Zaiji Pharmaceutical

Changzhou Hengbang Pharmaceutical

BeiGene

Ventyx Biosciences

Takeda (Nimbus Therapeutics)

Sareum Holdings Pic

Oncostellae

Galapagos NV

Bristol Myers Squibb

TYK2 Targeting Drugs Segment by Type

Single-target Inhibitors

Dual-target Inhibitors

TYK2 Targeting Drugs Segment by Application

Psoriasis

Systemic Lupus Erythematosus

Dermatitis

Arthritis

Others

TYK2 Targeting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global TYK2 Targeting Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions TYK2 Targeting Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify TYK2 Targeting Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze TYK2 Targeting Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TYK2 Targeting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TYK2 Targeting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TYK2 Targeting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the TYK2 Targeting Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global TYK2 Targeting Drugs industry.

Chapter 3: Detailed analysis of TYK2 Targeting Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of TYK2 Targeting Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of TYK2 Targeting Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. TYK2 Targeting Drugs Industry Trends Table 2. TYK2 Targeting Drugs Industry Drivers Table 3. TYK2 Targeting Drugs Industry Opportunities and Challenges Table 4. TYK2 Targeting Drugs Industry Restraints Table 5. Global TYK2 Targeting Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global TYK2 Targeting Drugs Revenue Share by Company (2021-2026) Table 7. Global TYK2 Targeting Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global TYK2 Targeting Drugs Sales Volume Share by Company (2021-2026) Table 9. Global TYK2 Targeting Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global TYK2 Targeting Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global TYK2 Targeting Drugs Key Company Manufacturing Base & Headquarters Table 12. Global TYK2 Targeting Drugs Company, Product Type & Application Table 13. Global TYK2 Targeting Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global TYK2 Targeting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single-target Inhibitors Table 18. Significant Companies of Dual-target Inhibitors Table 19. Global TYK2 Targeting Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global TYK2 Targeting Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global TYK2 Targeting Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global TYK2 Targeting Drugs Sales Volume Share by Type (2021-2026) Table 23. Global TYK2 Targeting Drugs Sales Volume Share by Type (2027-2032) Table 24. Global TYK2 Targeting Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global TYK2 Targeting Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global TYK2 Targeting Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global TYK2 Targeting Drugs Sales Value Share by Type (2021-2026) Table 28. Global TYK2 Targeting Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Psoriasis Table 30. Significant Companies of Systemic Lupus Erythematosus Table 31. Significant Companies of Dermatitis Table 32. Significant Companies of Arthritis Table 33. Significant Companies of Others Table 34. Global TYK2 Targeting Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global TYK2 Targeting Drugs Sales Volume by Application (2021-2026) & (K Units) Table 36. Global TYK2 Targeting Drugs Sales Volume by Application (2027-2032) & (K Units) Table 37. Global TYK2 Targeting Drugs Sales Volume Share by Application (2021-2026) Table 38. Global TYK2 Targeting Drugs Sales Volume Share by Application (2027-2032) Table 39. Global TYK2 Targeting Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global TYK2 Targeting Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global TYK2 Targeting Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global TYK2 Targeting Drugs Sales Value Share by Application (2021-2026) Table 43. Global TYK2 Targeting Drugs Sales Value Share by Application (2027-2032) Table 44. Global TYK2 Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global TYK2 Targeting Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global TYK2 Targeting Drugs Sales Market Share by Region (2021-2026) Table 47. Global TYK2 Targeting Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global TYK2 Targeting Drugs Sales Market Share by Region (2027-2032) Table 49. Global TYK2 Targeting Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global TYK2 Targeting Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global TYK2 Targeting Drugs Sales Value Share by Region (2021-2026) Table 52. Global TYK2 Targeting Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global TYK2 Targeting Drugs Sales Value Share by Region (2027-2032) Table 54. Global TYK2 Targeting Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global TYK2 Targeting Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global TYK2 Targeting Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global TYK2 Targeting Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 59. Global TYK2 Targeting Drugs Sales Market Share by Country (2021-2026) Table 60. Global TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global TYK2 Targeting Drugs Sales Market Share by Country (2027-2032) Table 62. Global TYK2 Targeting Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global TYK2 Targeting Drugs Sales Value Market Share by Country (2021-2026) Table 64. Global TYK2 Targeting Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global TYK2 Targeting Drugs Sales Value Market Share by Country (2027-2032) Table 66. Inventisbio Company Information Table 67. Inventisbio Business Overview Table 68. Inventisbio TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Inventisbio TYK2 Targeting Drugs Product Portfolio Table 70. Inventisbio Recent Development Table 71. Qiyuan Biotechnology Company Information Table 72. Qiyuan Biotechnology Business Overview Table 73. Qiyuan Biotechnology TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio Table 75. Qiyuan Biotechnology Recent Development Table 76. InnoCare Company Information Table 77. InnoCare Business Overview Table 78. InnoCare TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. InnoCare TYK2 Targeting Drugs Product Portfolio Table 80. InnoCare Recent Development Table 81. Guangzhou Zaiji Pharmaceutical Company Information Table 82. Guangzhou Zaiji Pharmaceutical Business Overview Table 83. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 85. Guangzhou Zaiji Pharmaceutical Recent Development Table 86. Changzhou Hengbang Pharmaceutical Company Information Table 87. Changzhou Hengbang Pharmaceutical Business Overview Table 88. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 90. Changzhou Hengbang Pharmaceutical Recent Development Table 91. BeiGene Company Information Table 92. BeiGene Business Overview Table 93. BeiGene TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. BeiGene TYK2 Targeting Drugs Product Portfolio Table 95. BeiGene Recent Development Table 96. Ventyx Biosciences Company Information Table 97. Ventyx Biosciences Business Overview Table 98. Ventyx Biosciences TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio Table 100. Ventyx Biosciences Recent Development Table 101. Takeda (Nimbus Therapeutics) Company Information Table 102. Takeda (Nimbus Therapeutics) Business Overview Table 103. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio Table 105. Takeda (Nimbus Therapeutics) Recent Development Table 106. Sareum Holdings Pic Company Information Table 107. Sareum Holdings Pic Business Overview Table 108. Sareum Holdings Pic TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio Table 110. Sareum Holdings Pic Recent Development Table 111. Oncostellae Company Information Table 112. Oncostellae Business Overview Table 113. Oncostellae TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Oncostellae TYK2 Targeting Drugs Product Portfolio Table 115. Oncostellae Recent Development Table 116. Galapagos NV Company Information Table 117. Galapagos NV Business Overview Table 118. Galapagos NV TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Galapagos NV TYK2 Targeting Drugs Product Portfolio Table 120. Galapagos NV Recent Development Table 121. Bristol Myers Squibb Company Information Table 122. Bristol Myers Squibb Business Overview Table 123. Bristol Myers Squibb TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio Table 125. Bristol Myers Squibb Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. TYK2 Targeting Drugs Distributors List Table 129. TYK2 Targeting Drugs Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. TYK2 Targeting Drugs Product Image Figure 2. Global TYK2 Targeting Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TYK2 Targeting Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global TYK2 Targeting Drugs Sales (2021-2032) & (K Units) Figure 5. Global TYK2 Targeting Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global TYK2 Targeting Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single-target Inhibitors Image Figure 10. Dual-target Inhibitors Image Figure 11. Global TYK2 Targeting Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global TYK2 Targeting Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global TYK2 Targeting Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global TYK2 Targeting Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global TYK2 Targeting Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global TYK2 Targeting Drugs Sales Value Share by Type (2021-2032) Figure 17. Psoriasis Image Figure 18. Systemic Lupus Erythematosus Image Figure 19. Dermatitis Image Figure 20. Arthritis Image Figure 21. Others Image Figure 22. Global TYK2 Targeting Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global TYK2 Targeting Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global TYK2 Targeting Drugs Sales Volume Share by Application (2021-2032) Figure 25. Global TYK2 Targeting Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global TYK2 Targeting Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global TYK2 Targeting Drugs Sales Value Share by Application (2021-2032) Figure 28. Global TYK2 Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global TYK2 Targeting Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global TYK2 Targeting Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global TYK2 Targeting Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America TYK2 Targeting Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. North America TYK2 Targeting Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe TYK2 Targeting Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe TYK2 Targeting Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific TYK2 Targeting Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific TYK2 Targeting Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America TYK2 Targeting Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. South America TYK2 Targeting Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa TYK2 Targeting Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa TYK2 Targeting Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. TYK2 Targeting Drugs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. TYK2 Targeting Drugs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Single-target Inhibitors
  • Dual-target Inhibitors
Applications
  • Psoriasis
  • Systemic Lupus Erythematosus
  • Dermatitis
  • Arthritis
  • Others
Companies covered
  • Inventisbio
  • Qiyuan Biotechnology
  • InnoCare
  • Guangzhou Zaiji Pharmaceutical
  • Changzhou Hengbang Pharmaceutical
  • BeiGene
  • Ventyx Biosciences
  • Takeda (Nimbus Therapeutics)
  • Sareum Holdings Pic
  • Oncostellae
  • Galapagos NV
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global TYK2 Targeting Drugs Sales Value (2021-2032)
  4. 1.2.2 Global TYK2 Targeting Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global TYK2 Targeting Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 TYK2 Targeting Drugs Market Dynamics
  1. 2.1 TYK2 Targeting Drugs Industry Trends
  2. 2.2 TYK2 Targeting Drugs Industry Drivers
  3. 2.3 TYK2 Targeting Drugs Industry Opportunities and Challenges
  4. 2.4 TYK2 Targeting Drugs Industry Restraints
3 TYK2 Targeting Drugs Market by Company
  1. 3.1 Global TYK2 Targeting Drugs Company Revenue Ranking in 2025
  2. 3.2 Global TYK2 Targeting Drugs Revenue by Company (2021-2026)
  3. 3.3 Global TYK2 Targeting Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global TYK2 Targeting Drugs Average Price by Company (2021-2026)
  5. 3.5 Global TYK2 Targeting Drugs Company Ranking (2024-2026)
  6. 3.6 Global TYK2 Targeting Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global TYK2 Targeting Drugs Company Product Type and Application
  8. 3.8 Global TYK2 Targeting Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global TYK2 Targeting Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 TYK2 Targeting Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 TYK2 Targeting Drugs Market by Type
  1. 4.1 TYK2 Targeting Drugs Type Introduction
  2. 4.1.1 Single-target Inhibitors
  3. 4.1.2 Dual-target Inhibitors
  4. 4.2 Global TYK2 Targeting Drugs Sales Volume by Type
  5. 4.2.1 Global TYK2 Targeting Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global TYK2 Targeting Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global TYK2 Targeting Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global TYK2 Targeting Drugs Sales Value by Type
  9. 4.3.1 Global TYK2 Targeting Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global TYK2 Targeting Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global TYK2 Targeting Drugs Sales Value Share by Type (2021-2032)
5 TYK2 Targeting Drugs Market by Application
  1. 5.1 TYK2 Targeting Drugs Application Introduction
  2. 5.1.1 Psoriasis
  3. 5.1.2 Systemic Lupus Erythematosus
  4. 5.1.3 Dermatitis
  5. 5.1.4 Arthritis
  6. 5.1.5 Others
  7. 5.2 Global TYK2 Targeting Drugs Sales Volume by Application
  8. 5.2.1 Global TYK2 Targeting Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global TYK2 Targeting Drugs Sales Volume by Application (2021-2032)
  10. 5.2.3 Global TYK2 Targeting Drugs Sales Volume Share by Application (2021-2032)
  11. 5.3 Global TYK2 Targeting Drugs Sales Value by Application
  12. 5.3.1 Global TYK2 Targeting Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global TYK2 Targeting Drugs Sales Value by Application (2021-2032)
  14. 5.3.3 Global TYK2 Targeting Drugs Sales Value Share by Application (2021-2032)
6 TYK2 Targeting Drugs Regional Sales and Value Analysis
  1. 6.1 Global TYK2 Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global TYK2 Targeting Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global TYK2 Targeting Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global TYK2 Targeting Drugs Sales by Region (2027-2032)
  5. 6.3 Global TYK2 Targeting Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global TYK2 Targeting Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global TYK2 Targeting Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global TYK2 Targeting Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global TYK2 Targeting Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America TYK2 Targeting Drugs Sales Value (2021-2032)
  12. 6.6.2 North America TYK2 Targeting Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe TYK2 Targeting Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe TYK2 Targeting Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific TYK2 Targeting Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific TYK2 Targeting Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America TYK2 Targeting Drugs Sales Value (2021-2032)
  21. 6.9.2 South America TYK2 Targeting Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa TYK2 Targeting Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa TYK2 Targeting Drugs Sales Value Share by Country, 2025 VS 2032
7 TYK2 Targeting Drugs Country-level Sales and Value Analysis
  1. 7.1 Global TYK2 Targeting Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global TYK2 Targeting Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global TYK2 Targeting Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global TYK2 Targeting Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global TYK2 Targeting Drugs Sales by Country (2027-2032)
  6. 7.4 Global TYK2 Targeting Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global TYK2 Targeting Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global TYK2 Targeting Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt TYK2 Targeting Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt TYK2 Targeting Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt TYK2 Targeting Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Inventisbio
  2. 8.1.1 Inventisbio Company Information
  3. 8.1.2 Inventisbio Business Overview
  4. 8.1.3 Inventisbio TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Inventisbio TYK2 Targeting Drugs Product Portfolio
  6. 8.1.5 Inventisbio Recent Developments
  7. 8.2 Qiyuan Biotechnology
  8. 8.2.1 Qiyuan Biotechnology Company Information
  9. 8.2.2 Qiyuan Biotechnology Business Overview
  10. 8.2.3 Qiyuan Biotechnology TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio
  12. 8.2.5 Qiyuan Biotechnology Recent Developments
  13. 8.3 InnoCare
  14. 8.3.1 InnoCare Company Information
  15. 8.3.2 InnoCare Business Overview
  16. 8.3.3 InnoCare TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 InnoCare TYK2 Targeting Drugs Product Portfolio
  18. 8.3.5 InnoCare Recent Developments
  19. 8.4 Guangzhou Zaiji Pharmaceutical
  20. 8.4.1 Guangzhou Zaiji Pharmaceutical Company Information
  21. 8.4.2 Guangzhou Zaiji Pharmaceutical Business Overview
  22. 8.4.3 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  24. 8.4.5 Guangzhou Zaiji Pharmaceutical Recent Developments
  25. 8.5 Changzhou Hengbang Pharmaceutical
  26. 8.5.1 Changzhou Hengbang Pharmaceutical Company Information
  27. 8.5.2 Changzhou Hengbang Pharmaceutical Business Overview
  28. 8.5.3 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  30. 8.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
  31. 8.6 BeiGene
  32. 8.6.1 BeiGene Company Information
  33. 8.6.2 BeiGene Business Overview
  34. 8.6.3 BeiGene TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BeiGene TYK2 Targeting Drugs Product Portfolio
  36. 8.6.5 BeiGene Recent Developments
  37. 8.7 Ventyx Biosciences
  38. 8.7.1 Ventyx Biosciences Company Information
  39. 8.7.2 Ventyx Biosciences Business Overview
  40. 8.7.3 Ventyx Biosciences TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio
  42. 8.7.5 Ventyx Biosciences Recent Developments
  43. 8.8 Takeda (Nimbus Therapeutics)
  44. 8.8.1 Takeda (Nimbus Therapeutics) Company Information
  45. 8.8.2 Takeda (Nimbus Therapeutics) Business Overview
  46. 8.8.3 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio
  48. 8.8.5 Takeda (Nimbus Therapeutics) Recent Developments
  49. 8.9 Sareum Holdings Pic
  50. 8.9.1 Sareum Holdings Pic Company Information
  51. 8.9.2 Sareum Holdings Pic Business Overview
  52. 8.9.3 Sareum Holdings Pic TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio
  54. 8.9.5 Sareum Holdings Pic Recent Developments
  55. 8.10 Oncostellae
  56. 8.10.1 Oncostellae Company Information
  57. 8.10.2 Oncostellae Business Overview
  58. 8.10.3 Oncostellae TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Oncostellae TYK2 Targeting Drugs Product Portfolio
  60. 8.10.5 Oncostellae Recent Developments
  61. 8.11 Galapagos NV
  62. 8.11.1 Galapagos NV Company Information
  63. 8.11.2 Galapagos NV Business Overview
  64. 8.11.3 Galapagos NV TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Galapagos NV TYK2 Targeting Drugs Product Portfolio
  66. 8.11.5 Galapagos NV Recent Developments
  67. 8.12 Bristol Myers Squibb
  68. 8.12.1 Bristol Myers Squibb Company Information
  69. 8.12.2 Bristol Myers Squibb Business Overview
  70. 8.12.3 Bristol Myers Squibb TYK2 Targeting Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio
  72. 8.12.5 Bristol Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 TYK2 Targeting Drugs Value Chain Analysis
  2. 9.1.1 TYK2 Targeting Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 TYK2 Targeting Drugs Sales Mode & Process
  6. 9.2 TYK2 Targeting Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 TYK2 Targeting Drugs Distributors
  9. 9.2.3 TYK2 Targeting Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst